Cochrane Renal Group

 Back
autoid 119
crg_id CRG030600051
titleoftrial Changes in serum parameters of iron metabolism by treatment in dialysis patients
acronymnoftrial iron regulators in dialysis patients
website http://
identificationno
leadprefix Dr
leadsurname Fukagawa
leadgivennames Masafumi
leadposition Associate Professor and Director
leaddepartment DIvision of Nephrology & Dialysis Center
leadorganisation Kobe University School of Medicine
leadaddress 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan
leademail fukagawa@med.kobe-u.ac.jp
leadphone +81 78 382 6500
leadfax +81 78 382 6509
leadsuffix
contactprefix Dr
contactsurname Tanaka
contactgivennames Motoko
contactposition Vice Director
contactdepartment Division of Nephrology
contactorganisation Akebono Clinic
contactaddress 5-1-1 Shirafuji, Kumamoto, 861-4112, Japan
contactemail tanaka@matusita-kai.or.jp
contactphone +81 96 358 7211
contactfax +81 96 358 7226
funding ngo
otherfunding
fundingnameofsponsors Renal anemia fund, Japan
ethicsapproval yes
studytype nonrandomised
studytype_other prospective observation during intervention
groupassignment parallel
blinding_patients no
blinding_investigators no
blinding_outcomes yes
blinding_analysts yes
proposedstart 1/2005
actualstart 1/2005
proposedcompletiondate 12/2005
actualcompletiondate 6/2006
multi_center_study yes
numberofcentres 2
multi_national_study no
countrycentres Japan
researchquestion To examine whether treatmant either by iron or erythropoietin treatment
study_status_recruitment no_longer_recruiting
study_status_recruitment_follow ongoing
healthcarecondition dialysis, anemia
intervention1 erythropoietin
intervention2 intreavenous iron preparation
intervention3
intervention4
participants_gender both
participants_other adults
age 20 or older
totalrecruitment 60
inclusion chronic dialysis patients with anemia, either with or without iron deficiency
exclusion acute or chronic inflammation
primaryoutcomes increase of hemoglobin concentration
secondaryoutcomes Changes in serum parameters of iron metabolism (iron, transferrin, ferritin, hepcidin)
reference Tsuchihashi D, Tanaka M, Nii-Kono T, Itoh K, Matsushita M, Abe T, Fukagawa M: Serum hepcidin levels and iron homeostasis in dialysis patients (abstract). J Am Soc Nephrol 16: 477A, 2005